Search

L3Harris Opens With Strong Third Quarter; Raises Earnings Outlook

L3Harris Opens With Strong Third Quarter; Raises Earnings Outlook
L3Harris Technologies Chairman and CEO William Brown. Photo: L3Harris Technologies

L3Harris Technologies [LHX] on Wednesday posted strong third quarter consolidated sales and earnings that combine the results of the former Harris Corp. and L3 Technologies and raised its guidance for earnings this year. Pro forma sales increased 10 percent to $4.4 billion from $4 billion a year ago and adjusted operating income grew 25 percent to $766 million, $2.58 earnings per share (EPS), from $612 million ($2.04 EPS), topping consensus estimates by 21 cents per share. Adjusted operating margins were…

Subscriber-only content. Please log in below.

Not a subscriber or registered user yet?

Please contact us at clientservices@accessintel.com or call us at 888-707-5814 (Monday – Thursday 9:00 a.m. – 5:30 p.m. and Friday 9:00 a.m. – 3:00 p.m. ET.), to start a free trial, get pricing information, order a reprint, or post an article link on your website.



Contract Updates

Intertrade Limited (Cedar Rapids, Iowa) – $9,272,637

Intertrade Limited, Cedar Rapids, Iowa, has been awarded a maximum $9,272,637 firm-fixed-price contract for F-16 generator controls. This was a sole-source acquisition using justification 10 U.S. Code 3204 (a)(1), as stated in Federal Acquisition Regulation 6.302-1. This is a four-year…


Cottonwood Inc. (Lawrence, Kansas) – $44,370,000

Cottonwood Inc.,** Lawrence, Kansas, has been awarded a maximum $44,370,000 firm-fixed-price, indefinite-quantity contract for aircraft cargo tie down straps. This was a sole-source acquisition using justification 10 U.S. Code 3204 (a)(5), as stated in Federal Acquisition Regulation 8.7. This is…


Teva Pharmaceuticals USA Inc. (Parsippany, New Jersey) – $46,087,497

Teva Pharmaceuticals USA Inc., Parsippany, New Jersey, has been awarded a maximum $46,087,497 modification (P00009) exercising the third one-year option period of a five-year base contract (SPE2DP-20-D-0002) with five one-year option periods for adenovirus type 4 and type 7 vaccines.…


Northrop Grumman Systems Corp. (Oklahoma City, Oklahoma) – $64,111,631

Northrop Grumman Systems Corp., Oklahoma City, Oklahoma, has been awarded an estimated $64,111,631 delivery order (SPRTA1-26-F-0034) and modification (P00015) to a four-year subsumable base contract (SPRTA1-19-D-0001) with one five-year option period for additional pricing for the manufacture and production of…